ReviewJournal of Cancer2019

Immune-Checkpoint Inhibitors as the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.

Yuqiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.